Decreased haematocrit after Velagliflozin (Senvelgo) in cats
The FDA has received 20 reports of decreased haematocrit in cats after Velagliflozin. That is 0.4% of all reports for this medicine, compared with 0.2% across reports for all cat medicines, so it is reported unusually often with this medicine.
20Reports
80%Marked serious
0.0%Recovered
45%Died or euthanised
12 daysTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Velagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).
Products with this ingredient include Senvelgo. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Velagliflozin cause decreased haematocrit in cats?
- 20 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 12 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Decreased haematocrit with similar medicines
- Decreased haematocrit after Bexagliflozin (Bexacat) 52 reports · 1.3% of its reports
- Decreased haematocrit after Insulin 22 reports · 0.6% of its reports
- Decreased haematocrit after Methimazole 34 reports · 1.9% of its reports
All reported side effects of Velagliflozin in cats · Medicines most reported with decreased haematocrit